Stockreport

ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance [Yahoo! Finance]

Elite Pharmaceuticals, Inc.  (ELTP) 
NASDAQ:AMEX Investor Relations: ir.elitepharma.com
PDF This compares with the S&P 500 Index's 2.2% loss over the same period. Over the past month, Elite stock plunged 4.9%, while the S&P 500 slipped 2%. ELTP's Earnings and [Read more]